Understanding the effect of cognitive/brain reserve and depression on regional atrophy in early Alzheimer’s disease

References

• Lee HB, Lyketsos CG. Depression in Alzheimer’s disease: heterogeneity and related issues. Biol Psychiatry. 2003;54(3):353–362.
   PubMed Web of Science ®Google Scholar
• Germain S, Adam S, Olivier C, et al. Does cognitive impairment influence burden in caregivers of patients with Alzheimer’s disease? J Alzheimers Dis. 2009;17(1):105–114.
   PubMed Web of Science ®Google Scholar
• Missotten P, Squelard G, Ylieff M, et al. Relationship between quality of life and cognitive decline in dementia. Dement Geriatr Cogn Disord. 2008;25(6):564–572.
   PubMed Web of Science ®Google Scholar
• Steele C, Rovner B, Chase GA, et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry. 1990;147(8):1049–1051.
   PubMed Web of Science ®Google Scholar
• Rapp MA, Schnaider-Beeri M, Wysocki M, et al. Cognitive decline in patients with dementia as a function of depression. Am J Geriatr Psychiatry. 2011;19(4):357–363.
   PubMed Web of Science ®Google Scholar
• Yatawara C, Lim L, Chander R, et al. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2016;87(12):1375–1383.
   PubMed Web of Science ®Google Scholar
• Hudon C, Belleville S, Gauthier S. The association between depressive and cognitive symptoms in amnestic mild cognitive impairment. Int Psychogeriatr. 2008;20(4):710–723.
   PubMed Web of Science ®Google Scholar
• Xie C, Li W, Chen G, et al. The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study. Behav Brain Res. 2012;235(2):244–250.
   PubMed Web of Science ®Google Scholar
• Son JH, Han DH, Min KJ, et al. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer’s disease. Neurosci Lett. 2013;548:15–20.
   PubMed Web of Science ®Google Scholar
• Lebedeva A, Westman E, Lebedev AV, et al. Structural brain changes associated with depressive symptoms in the elderly with Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2014;85(8):930–935.
   PubMed Web of Science ®Google Scholar
• Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448–460.
   PubMed Web of Science ®Google Scholar
• Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015–2028.
   PubMed Web of Science ®Google Scholar
• Stern Y, Arenaza-Urquijo EM, Bartres-Faz D, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33491-5. doi: 10.1016/j.jalz.2018.07.219. [Epub ahead of print].
   Google Scholar
• Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(2):112–117.
   PubMed Web of Science ®Google Scholar
• Amieva H, Mokri H, Le Goff M, et al. Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline. Brain. 2014;137(4):1167–1175.
   PubMedGoogle Scholar
• Erten-Lyons D, Woltjer RL, Dodge H, et al. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology. 2009;72(4):354–360.
   PubMed Web of Science ®Google Scholar
• Brayne C, Ince PG, Keage HA, et al. Education, the brain and dementia: neuroprotection or compensation? Brain. 2010;133(8):2210–2216.
   PubMedGoogle Scholar
• Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 2012;11(11):1006–1012.
   PubMed Web of Science ®Google Scholar
• Serra L, Cercignani M, Petrosini L, et al. Neuroanatomical correlates of cognitive reserve in Alzheimer disease. Rejuvenation Res. 2011;14(2):143–151.
   PubMed Web of Science ®Google Scholar
• Opdebeeck C, Matthews FE, Wu YT, et al. Cognitive reserve as a moderator of the negative association between mood and cognition: evidence from a population-representative cohort. Psychol Med. 2018;48(1):61–71.
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279.
   PubMed Web of Science ®Google Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage. 2012;59(4):3774–3783.
   PubMed Web of Science ®Google Scholar
• Fillenbaum GG, van Belle G, Morris JC, et al. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): the first twenty years. Alzheimers Dement. 2008;4(2):96–109.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Grundman M, Sencakova D, Jack CR Jr., et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci. 2002;19(1–2):23–27.
   PubMed Web of Science ®Google Scholar
• Garibotto V, Borroni B, Kalbe E, et al. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology. 2008 Oct 21;71(17):1342–1349.
   PubMed Web of Science ®Google Scholar
• Bora E, Fornito A, Pantelis C, et al. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord. 2012;138(1–2):9–18.
   PubMed Web of Science ®Google Scholar
• Kempton MJ, Salvador Z, Munafò MR, et al. Structural neuroimaging studies in major depressive disorder Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry. 2011;68(7):675–690.
   PubMed Web of Science ®Google Scholar
• Lupo M, Siciliano L, Leggio M. From cerebellar alterations to mood disorders: A systematic review. Neurosci Biobehav Rev. 2019;103:21–28.
   PubMed Web of Science ®Google Scholar
• Hämäläinen A, Tervo S, Grau-Olivares M, et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage. 2007;37(4):1122–1131.
   PubMed Web of Science ®Google Scholar
• Schultz SA, Gordon BA, Mishra S, et al. Widespread distribution of tauopathy in preclinical Alzheimer’s disease. Neurobiol Aging. 2018;72:177–185.
   PubMed Web of Science ®Google Scholar
• Shimoda K, Kimura M, Yokota M, et al. Comparison of regional gray matter volume abnormalities in Alzheimers disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study. Psychiatry Res. 2015;232(1):71–75.
   PubMed Web of Science ®Google Scholar
• Wang S, Blazer DG. Depression and cognition in the elderly. Annu Rev Clin Psychol. 2015;11:331–360.
   PubMed Web of Science ®Google Scholar
• Kolanowski A, Boltz M, Galik E, et al. Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence. Nurs Outlook. 2017;65(5):515–529.
   PubMed Web of Science ®Google Scholar
• Boyle LL, Richardson TM, He H, et al. How do the PHQ-2, the PHQ-9 perform in aging services clients with cognitive impairment? Int J Geriatr Psychiatry. 2011 Sep;26(9):952–960.
   PubMed Web of Science ®Google Scholar